Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

670
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
670
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

599
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
599
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory logic underlying neural crest contributions to the head versus the heart.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology.

Orphanet journal of rare diseases·2026
Same author

Temporal Increases in Mercury Concentrations are Associated with Increased Risk of Death by Infectious Disease in Harbour Porpoises (<i>Phocoena Phocoena)</i>.

Environmental science & technology·2025
Same author

Lived-experience perspectives on the psychological factors linking childhood maltreatment to later intimate partner violence victimization.

European journal of psychotraumatology·2025
Same author

Assessment of Pain Types in Recently Diagnosed Patients With Inflammatory Arthritis.

Arthritis care & research·2025
Same author

Older Aboriginal and Torres Strait Islander populations living with dementia: State and territory scenario-based projections into the future.

Australasian journal on ageing·2025
Same journal

Compassion fatigue among critical care nurses: a literature review.

Nursing management (Harrow, London, England : 1994)·2026
Same journal

Repositioning entrepreneurial competence as a core nursing capability: unlocking nurses' leadership and innovation potential.

Nursing management (Harrow, London, England : 1994)·2026
Same journal

How to design and deliver a nurse fellowship.

Nursing management (Harrow, London, England : 1994)·2026
Same journal

Relationship between leadership transparency and workplace cynicism among nurses: a systematic review and meta-analysis.

Nursing management (Harrow, London, England : 1994)·2026
Same journal

Strengthening nurses' recognition of, and response to, domestic violence and abuse.

Nursing management (Harrow, London, England : 1994)·2026
Same journal

From strain to strength: enhancing the benefits of employing temporary nurses.

Nursing management (Harrow, London, England : 1994)·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.3K

Critical care.

Ruth Williams

    Nursing Management (Harrow, London, England : 1994)
    |November 26, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Critical care professionals can access drug alerts and safety information from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA website provides up-to-date guidance for enhanced patient safety in critical care settings.

    More Related Videos

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
    10:38

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

    Published on: January 16, 2019

    21.0K
    Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
    09:17

    Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

    Published on: May 2, 2017

    9.5K

    Related Experiment Videos

    Last Updated: Mar 13, 2026

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
    09:36

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

    Published on: September 24, 2020

    3.3K
    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
    10:38

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

    Published on: January 16, 2019

    21.0K
    Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
    09:17

    Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

    Published on: May 2, 2017

    9.5K

    Area of Science:

    • Pharmacovigilance
    • Critical Care Medicine
    • Regulatory Science

    Background:

    • Healthcare professionals require timely access to drug safety information.
    • Critical care settings necessitate rapid updates on medication risks and guidance.
    • Regulatory agencies play a vital role in disseminating safety alerts.

    Purpose of the Study:

    • To inform critical care professionals about the availability of drug safety information.
    • To direct healthcare providers to a centralized resource for regulatory updates.
    • To enhance the safe use of medicines in critical care.

    Main Methods:

    • Information dissemination via the Medicines and Healthcare products Regulatory Agency (MHRA) website.
    • Publication of drug alerts, medical safety alerts, and guidance.
    • Targeted information for critical care practitioners.

    Main Results:

    • A dedicated section on the MHRA website provides critical care practitioners with essential safety information.
    • Up-to-date guidance and alerts are readily accessible.
    • The website serves as a primary source for regulatory drug safety communications.

    Conclusions:

    • The MHRA website is a key resource for critical care professionals seeking drug safety information.
    • Accessible regulatory information supports evidence-based practice in critical care.
    • Proactive communication of safety data is crucial for patient safety in critical care.